AbbVie’s $10.9B Apogee deal strengthens immunology beyond Humira, adds Zumilokibart optionality, and may be undervalued. See ...
Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results